Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrous sulfate dose comparison for prevention of recurrent febrile convulsion
IRCT20200728048243N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ferrous sulfate in febrile seizure (FS) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Recurrence of febrile convulsion. Started May 2021; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on IRCT20200728048243N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200728048243N1.